Early stage IT and Healthcare Investing

Tizona Therapeutics

portfoliocompanies

company snapshot

Tizona Therapeutics

Tizona Therapeutics, Inc. is a preclinical stage biotechnology company that is developing multiple, innovative immuno-oncology therapies. Tizona Therapeutics, Inc. was founded by MPM Capital and leading scientists from Dana Farber Cancer Institute, the University of Pittsburgh, Johns Hopkins, Memorial Sloan Kettering Cancer Center, and Brigham and Women’s Hospital.

website
http://tizonatx.com/
Leadership
Follow The Company
Investment Team
Pablo Cagnoni, President & CEO
Facebook Google+ Twitter Email LinkedIn Share